Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Deciphering Replication Readiness and Its Role in Genome Duplication Surveillance

Obiettivo

Errors in DNA replication are a major driver of human disease—up to two-thirds of all cancers originate from faults in this process. While we understand how cells replicate their DNA once the process begins, we know far less about how they prepare for this critical event. How do cells determine they are ready to copy their genome, and what happens when this readiness fails?

Building on recent discoveries from my lab, I propose that before entering S phase, cells undergo a tightly regulated state of replication readiness—an inheritable condition that preconfigures accurate genome duplication across generations. My data suggest this readiness precedes the G1 phase and relies on the mother cell passing the key molecular components of replication readiness to daughter cells. This creates a form of cellular memory that ensures replication fidelity across generations. The REWIRE project will define how replication readiness is established, monitored, and re-established under stress. I hypothesize the existence of a previously unrecognized G2/M surveillance mechanism—a maternal replication readiness checkpoint—safeguarding the handover of replication competence to progeny. I will also investigate how this process is established de novo during tissue regeneration—a costly and error-prone transition that may compromise genome stability.

To this end, I will use advanced tools developed in my lab, including inducible protein degradation, CRISPR-based editing, and AI-assisted single-cell and single-molecule imaging pipelines. Using small intestinal organoids, I will cross-examine inherited and de novo replication readiness and link it to tissue-level outcomes in regeneration and disease. By uncovering how cells preconfigure genome duplication before it begins, REWIRE will redefine the logic of DNA replication control, reveal new mechanisms safeguarding genome stability, and uncover vulnerabilities that could be targeted in cancer and other replication-driven disorders.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-STG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

BIOFYZIKALNI USTAV AKADEMIE VED CESKE REPUBLIKY
Contributo netto dell'UE
€ 1 999 875,00
Indirizzo
Kralovopolska 135
612 65 Brno
Cechia
Regione
Česko Jihovýchod Jihomoravský kraj
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 999 875,00

Beneficiari (1)